- 商品介绍
- 规格参数
- 包装参数
Application
VAHA may be used in cell signaling studies.
Biochem/physiol Actions
Hydroxamic acid derivatives of valproic acid exhibit anticonvulsant activity with no teratogenic activity in mouse neural tube defect model. It is effective in the treatment of bipolar disorders.
VAHA (Valproyl hydroxamic acid) is an HDAC inhibitor with less activity than valproic acid against Class I enzymes but much greater Class II activity
VAHA is an HDAC inhibitor
Features and Benefits
This compound is a featured product for Gene Regulation research. Click here to discover more featured Gene Regulation products. Learn more about bioactive small molecules for other areas of research at sigma.com/discover-bsm.
| Quality Segment | 100 |
| assay | ≥98% (HPLC) |
| form | powder |
| solubility | DMSO: ≥25 mg/mL |
| storage temp. | 2-8°C |
| SMILES string | CCCC(CCC)C(=O)NO |
| InChI | 1S/C8H17NO2/c1-3-5-7(6-4-2)8(10)9-11/h7,11H,3-6H2,1-2H3,(H,9,10) |
| InChI key | ROJGIRXXBBBMPL-UHFFFAOYSA-N |
| 长度(mm) | |
| 宽度(mm) | |
| 高度(mm) | |
| 重量(kg) |
-
¥ 1148.92
-
询价
-
询价
-
¥ 6894.69
-
¥ 9737.84
-
¥ 238.17
-
询价
-
询价
-
询价
-
¥ 10277.12
-
¥ 3335.66
-
¥ 1156.91
-
¥ 2406.69
-
¥ 9909.51
-
¥ 66743.99
-
¥ 8072.66
-
¥ 18741.69
-
¥ 58184.19
-
¥ 21144.84
-
¥ 15894.19
微信小程序
7X24小时在线咨询